Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag
Go back to Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag| Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) | Delayed: 30.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.98 | 52 Week High | $31.02 | |||
| Open | $3.30 | 52 Week Low | $8.03 | |||
| Day High | $30.98 | P/E | N/A | |||
| Day Low | $30.98 | EPS | $-4.38 | |||
| Volume | 440,704 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,817,855 | |||||
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.61 +1.56 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.05 | 52 Week High | $77.12 | |||
| Open | $66.80 | 52 Week Low | $49.03 | |||
| Day High | $68.64 | P/E | 43.90 | |||
| Day Low | $66.61 | EPS | $1.54 | |||
| Volume | 13,898,733 | |||||
